Press releases | WebDisclosure

Basculer en Français

10238	Companies
211366	Keywords
141300	Articles
111975	Press releases

Home
Press releases

PRESS RELEASE

published on 01/21/2026 at 18:00, 2 months 29 days ago

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
OSE Immunotherapeutics acknowledges FDA Orphan Drug Designation granted to pegrizeprument (VEL-101) for organ rejection prevention in liver transplant patients. Veloxis Pharmaceuticals to develop and commercialize the product globally

FDA Orphan Drug Designation OSE Immunotherapeutics Pegrizeprument VEL-101
PRESS RELEASE

published on 01/21/2026 at 17:47, 2 months 29 days ago

CPI PROPERTY GROUP – Sustainable Finance Update
CPI Property Group announces update of Sustainable Finance Framework and release of first European Green Bond Factsheet, validated by Moody's

CPI Property Group ESG Moody's Sustainable Finance European Green Bond
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

Michelin Free Cash Flow exceeds forecast in 2025
Michelin Group surpasses 2025 Free Cash Flow forecast, driven by Capex discipline and operational efficiency. Segment Operating Income range confirmed. Audited results to be released on February 11, 2026

Free Cash Flow 2025 Financial Results Michelin Group Capex Discipline Segment Operating Income
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

Michelin délivre en 2025 une génération de trésorerie supérieure à la prévision
Michelin délivre en 2025 une génération de trésorerie supérieure à la prévision. Le Groupe annonce un free cash-flow de 2,1 milliards d'euros, dépassant les attentes initiales

Performance Trésorerie Résultat Financier Michelin Free Cash-flow
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
Arbitration tribunal supports Ipsen's termination of R&D agreement with Galderma. ICC Tribunal's decision confirms Ipsen's rights to toxin programs in the aesthetic field

Ipsen Arbitration Tribunal Galderma R&D Agreement ICC Tribunal
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

Le tribunal arbitral confirme la résiliation par Ipsen de l'accord de R&D conclu avec Galderma
Le tribunal arbitral confirme la résiliation par Ipsen de l'accord de R&D conclu avec Galderma. Ipsen obtient la totalité des droits sur ses programmes toxines en phase clinique dans l’esthétique

Ipsen Galderma Tribunal Arbitral IPN10200 Accord De R&D
REGULATED PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

CIS : Chiffre d’affaires 2025
CIS enregistre une croissance de 15,7% en 2025, portée par l'Afrique et l'Eurasie. Objectif : dépasser 500 M€ de CA à moyen terme

Croissance CIS Afrique 500 M€ Eurasie
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

POUJOULAT SA : Achats effectués dans les conditions de l'article 5 du Règlement Abus de Marché 12/01/2026
Achats effectués dans les conditions de l'article 5 du Règlement Abus de Marché par POUJOULAT SA en 2026 sur Euronext Growth Paris

Euronext Growth Paris Règlement Abus De Marché Achats POUJOULAT SA 2026
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

Nombre de droits de vote et d'actions au 31 Decembre 2025
SRP GROUPE dévoile les informations relatives au nombre total de droits de vote et d'actions conformément aux règles du Code de commerce et du Règlement de l'AMF

Droits De Vote Code De Commerce Actions AMF SRP Groupe
PRESS RELEASE

published on 01/21/2026 at 17:45, 2 months 29 days ago

Informations privilégiées / Autres communiqués
Mauna Kea Technologies annonce son agenda financier 2026 et sa participation à des forums investisseurs pour présenter ses avancées. La société reprend sa communication après une restructuration en 2025

Partenariats Stratégiques Agenda Financier Mauna Kea Technologies Cellvizio Forums Investisseurs

Accesswire

Published on 04/20/2026 at 02:25, 15 minutes ago

First Challenger Assays Return Grades up to 170g/t Au
Published on 04/18/2026 at 04:00, 1 day 22 hours ago

Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 2 days ago

AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 2 days 1 hour ago

Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 2 days 1 hour ago

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development

View all ACCESSWIRE

EQS Group

Published on 04/18/2026 at 00:05, 2 days 2 hours ago

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 21:39, 2 days 5 hours ago

Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Published on 04/17/2026 at 20:33, 2 days 6 hours ago

LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:35, 2 days 7 hours ago

Stabilisation Notice
Published on 04/17/2026 at 19:30, 2 days 7 hours ago

KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS

Les Echos

Published on 04/17/2026 at 20:30, 2 days 6 hours ago

ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/17/2026 at 19:00, 2 days 7 hours ago

Cegedim : Publication du Document d’Enregistrement Universel 2025
Published on 04/17/2026 at 19:00, 2 days 7 hours ago

Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 2 days 8 hours ago

Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 17:45, 2 days 8 hours ago

Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın

View all LES ECHOS COMFI WIRE